Neuroprotective Properties of Dehydroepiandrosterone-sulfate and Its Relationship to Interleukin 6 After Aneurysmal Subarachnoid Hemorrhage: a Prospective Cohort Study

Overview

Journal Crit Care

Specialty Critical Care

Date 2015 May 22

PMID 25993987

Citations 10

Authors

Anke Hollig

Miriam Thiel

Birgit Stoffel-Wagner

Mark Coburn

Hans Clusmann

Affiliations

Soon will be listed here.

Abstract

Introduction: The established neuroprotective property of the sex steroid precursor dehydroepiandrosterone-sulfate (DHEAS) has not yet been investigated in the context of aneurysmal subarachnoid hemorrhage (aSAH). The influence of DHEAS on inflammatory response resulting in modulation of interleukin 6 (IL-6) synthesis has been shown. Here, we evaluate DHEAS serum levels after aSAH (day 0-14) and levels of IL-6 related to functional outcome at discharge and at six months.

Methods: A complete data set (DHEAS and IL-6 serum levels for days 0, 1, 4, 7, 10 and 14 after aSAH) and outcome assessment at discharge according to modified Rankin Scale score (mRS) was available for 53 patients of the initially screened cohort (n = 109). Outcome assessment six months after aSAH was obtained from 41 patients. Logarithmized levels of DHEAS and IL-6 were related to dichotomized functional outcome either assessed at discharge or at six months. A mixed between-within subjects ANOVA was applied for statistical analysis (SPSS 21.0).

Results: DHEAS and IL-6 levels across time were related to functional outcome. Regarding outcome assessment at discharge and at six months after aSAH, DHEAS levels (transformed to square root for statistical purposes) were considerably higher in patients with favorable outcome (mRS 0-2) (p = .001; p = .020). Inversely, in patients with favorable outcome either at discharge or six months after aSAH, lower IL-6 levels (logarithmized for statistical purposes) were observed across time (both p < .001).

Conclusion: We provide new evidence that DHEAS is associated with protective properties resulting in improvement of functional outcome after aSAH, possibly by influencing the inflammatory response after aSAH shown in the decreasing IL-6 serum levels. But the results for outcome six months after SAH are limited due to a high drop-out rate.

Citing Articles

A Systematic Review of Inflammatory Cytokine Changes Following Aneurysmal Subarachnoid Hemorrhage in Animal Models and Humans.

Devlin P, Ishrat T, Grimes Stanfill A Transl Stroke Res. 2022; 13(6):881-897.

PMID: 35260989 DOI: 10.1007/s12975-022-01001-y.

Interleukin-6: Important Mediator of Vasospasm Following Subarachnoid Hemorrhage.

Lucke-Wold B, Hosaka K, Dodd W, Motwani K, Laurent D, Martinez M Curr Neurovasc Res. 2021; 18(3):364-369.

PMID: 34736380 PMC: 10127255. DOI: 10.2174/1567202618666211104122408.

Interleukin 6 and Aneurysmal Subarachnoid Hemorrhage. A Narrative Review.

Simon M, Grote A Int J Mol Sci. 2021; 22(8).

PMID: 33923626 PMC: 8073154. DOI: 10.3390/ijms22084133.

Dehydroepiandrosterone Supplementation May Benefit Women with Asthma Who Have Low Androgen Levels: A Pilot Study.

Marozkina N, Zein J, DeBoer M, Logan L, Veri L, Ross K Pulm Ther. 2020; 5(2):213-220.

PMID: 32026412 PMC: 6967310. DOI: 10.1007/s41030-019-00101-9.

DHEA Attenuates Microglial Activation via Induction of JMJD3 in Experimental Subarachnoid Haemorrhage.

Tao T, Liu G, Shi X, Zhou Y, Lu Y, Gao Y J Neuroinflammation. 2019; 16(1):243.

PMID: 31779639 PMC: 6883548. DOI: 10.1186/s12974-019-1641-y.

References

Straub R, Konecna L, Hrach S, Rothe G, Kreutz M, Scholmerich J . Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab. 1998; 83(6):2012-7. DOI: 10.1210/jcem.83.6.4876. View

Rupprecht R, Holsboer F . Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci. 1999; 22(9):410-6. DOI: 10.1016/s0166-2236(99)01399-5. View

Marques-Deak A, Cizza G, STERNBERG E . Brain-immune interactions and disease susceptibility. Mol Psychiatry. 2005; 10(3):239-50. DOI: 10.1038/sj.mp.4001643. View

Feigin V, Rinkel G, Lawes C, Algra A, Bennett D, van Gijn J . Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke. 2005; 36(12):2773-80. DOI: 10.1161/01.STR.0000190838.02954.e8. View

Bauer S, Kerr B, Patterson P . The neuropoietic cytokine family in development, plasticity, disease and injury. Nat Rev Neurosci. 2007; 8(3):221-32. DOI: 10.1038/nrn2054. View

Maninger N, Wolkowitz O, Reus V, Epel E, Mellon S . Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol. 2008; 30(1):65-91. PMC: 2725024. DOI: 10.1016/j.yfrne.2008.11.002. View

Suzuki S, Tanaka K, Suzuki N . Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab. 2008; 29(3):464-79. DOI: 10.1038/jcbfm.2008.141. View

Deverman B, Patterson P . Cytokines and CNS development. Neuron. 2009; 64(1):61-78. DOI: 10.1016/j.neuron.2009.09.002. View

Lovelock C, Rinkel G, Rothwell P . Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review. Neurology. 2010; 74(19):1494-501. PMC: 2875923. DOI: 10.1212/WNL.0b013e3181dd42b3. View

10.

Al-Khindi T, Loch Macdonald R, Schweizer T . Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010; 41(8):e519-36. DOI: 10.1161/STROKEAHA.110.581975. View

11.

Dodel R, Winter Y, Ringel F, Spottke A, Gharevi N, Muller I . Cost of illness in subarachnoid hemorrhage: a German longitudinal study. Stroke. 2010; 41(12):2918-23. DOI: 10.1161/STROKEAHA.110.586826. View

12.

Dong Y, Zheng P . Dehydroepiandrosterone sulphate: action and mechanism in the brain. J Neuroendocrinol. 2011; 24(1):215-24. DOI: 10.1111/j.1365-2826.2011.02256.x. View

13.

Sehba F, Hou J, Pluta R, Zhang J . The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol. 2012; 97(1):14-37. PMC: 3327829. DOI: 10.1016/j.pneurobio.2012.02.003. View

14.

Connolly Jr E, Rabinstein A, Carhuapoma J, Derdeyn C, Dion J, Higashida R . Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke. 2012; 43(6):1711-37. DOI: 10.1161/STR.0b013e3182587839. View

15.

Algra A, Klijn C, Helmerhorst F, Algra A, Rinkel G . Female risk factors for subarachnoid hemorrhage: a systematic review. Neurology. 2012; 79(12):1230-6. DOI: 10.1212/WNL.0b013e31826aace6. View

16.

Erta M, Quintana A, Hidalgo J . Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012; 8(9):1254-66. PMC: 3491449. DOI: 10.7150/ijbs.4679. View

17.

Maingat F, Polyak M, Paul A, Vivithanaporn P, Noorbakhsh F, Ahboucha S . Neurosteroid-mediated regulation of brain innate immunity in HIV/AIDS: DHEA-S suppresses neurovirulence. FASEB J. 2012; 27(2):725-37. DOI: 10.1096/fj.12-215079. View

18.

Muroi C, Hugelshofer M, Seule M, Tastan I, Fujioka M, Mishima K . Correlation among systemic inflammatory parameter, occurrence of delayed neurological deficits, and outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2012; 72(3):367-75. DOI: 10.1227/NEU.0b013e31828048ce. View

19.

Yan F, Hu Q, Chen J, Wu C, Gu C, Chen G . Progesterone attenuates early brain injury after subarachnoid hemorrhage in rats. Neurosci Lett. 2013; 543:163-7. DOI: 10.1016/j.neulet.2013.03.005. View

20.

Kao C, Chang C, Su Y, Tsai Y, Chang K, Lin T . 17β-Estradiol attenuates secondary injury through activation of Akt signaling via estrogen receptor alpha in rat brain following subarachnoid hemorrhage. J Surg Res. 2013; 183(1):e23-30. DOI: 10.1016/j.jss.2013.01.033. View